Retinopathy in young retinoblastoma patients receiving a chemotherapy treatment: clinical trials and morphometric analysis.
Conclusion: Profound morphometric disturbances that come with combined chemotherapy call for a more careful treatment with methods selected in terms of OCT findings and specific chemotherapy contraindications.
PMID: 31922451 [PubMed - as supplied by publisher]
Source: Ophthalmic Genetics - Category: Opthalmology Tags: Ophthalmic Genet Source Type: research
More News: Anatomy | Chemotherapy | Clinical Trials | Eye Cancers | Eyes | Genetics | Ophthalmoscopy | Opthalmology | Retinoblastoma | Vitamin A